leukemia
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
We have analyzed the expression pattern of the entire HOX 1 locus in a panel of leukemia-derived human cell lines representing various blood phenotypes.
|
1348930 |
1992 |
Childhood Leukemia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
We have analyzed the expression pattern of the entire HOX 1 locus in a panel of leukemia-derived human cell lines representing various blood phenotypes.
|
1348930 |
1992 |
Malignant neoplasm of breast
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We conclude that loss of expression of p53 in human breast cancer may be primarily due to lack of expression of HOXA5.
|
10879542 |
2000 |
Breast Carcinoma
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
The majority of breast carcinomas show reduced or no expression of the transcription factor, HOXA5.
|
10875927 |
2000 |
Breast Carcinoma
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
We conclude that loss of expression of p53 in human breast cancer may be primarily due to lack of expression of HOXA5.
|
10879542 |
2000 |
Mammary Neoplasms
|
0.040 |
PosttranslationalModification
|
group |
BEFREE |
The HOXA5 promoter region was methylated in 16 out of 20 p53-negative breast tumour specimens.
|
10879542 |
2000 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
Genes affected by epigenetic changes in breast cancers include HoxA5, p21WAF, gelsolin, BRCA1, BRCA2, E-cadherin, steroid hormone receptors, and retinoic acid receptor II.
|
11501577 |
2001 |
Idiopathic pulmonary hypertension
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A 2.5-fold increase in HOXA5 mRNA expression was demonstrated by quantitative reverse transcriptase-polymerase chain reaction in primary pulmonary hypertension lung specimens when compared to normal lung tissue.
|
11238043 |
2001 |
Idiopathic pulmonary arterial hypertension
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
A 2.5-fold increase in HOXA5 mRNA expression was demonstrated by quantitative reverse transcriptase-polymerase chain reaction in primary pulmonary hypertension lung specimens when compared to normal lung tissue.
|
11238043 |
2001 |
Dwarfism
|
0.010 |
Biomarker
|
disease |
BEFREE |
Transgenic mice expressing the homeobox gene Hoxa5 under the control of Hoxb2 regulatory elements present a growth arrest during weeks two and three of postnatal development, resulting in proportionate dwarfism.
|
12163409 |
2002 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
To determine whether p53-independent apoptotic pathways are involved in HOXA5-induced cell death, we engineered a p53-mutant breast cancer cell line, Hs578T, to inducibly express HOXA5.
|
14701762 |
2004 |
Breast Carcinoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
To determine whether p53-independent apoptotic pathways are involved in HOXA5-induced cell death, we engineered a p53-mutant breast cancer cell line, Hs578T, to inducibly express HOXA5.
|
14701762 |
2004 |
Mammary Neoplasms
|
0.040 |
AlteredExpression
|
group |
LHGDN |
HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8.
|
14701762 |
2004 |
Malignant neoplasm of breast
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We have shown that loss of p53 correlated with loss of a developmentally regulated transcription factor, HOXA5, in primary breast cancer.
|
15545268 |
2005 |
Breast Carcinoma
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
We have shown that loss of p53 correlated with loss of a developmentally regulated transcription factor, HOXA5, in primary breast cancer.
|
15545268 |
2005 |
Carcinogenesis
|
0.050 |
Biomarker
|
phenotype |
BEFREE |
The homeotic gene HOXA5 has been shown to play an important role in breast tumorigenesis.
|
15545268 |
2005 |
Werner Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Gene expression changes that were common to all three cell types included up-regulation of GCK (glucokinase), CS (citrate synthase), HOX1 (heme oxygenase 1), CKMT2 (mitochondrial creatine kinase 2), MYC (v-myc myelocytomatosis viral oncogene homolog), and WRN (Werner syndrome helicase), and down-regulation of FBP1 (fructose-1, 6-bisphosphatase 1) and COL4A1 (collagen, type IV, alpha 1).
|
15561107 |
2005 |
Neoplasms
|
0.100 |
PosttranslationalModification
|
group |
BEFREE |
The downstream, evolutionary conserved island of HOXA5 showed hypomethylation in 18 tumors and complete methylation in others.
|
16575877 |
2006 |
Breast Carcinoma
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
In addition, we demonstrate that HOXA5 protein expression levels in breast carcinomas inversely co-relates with Epidermal Growth Factor Receptor (EGFR) expression.
|
17167183 |
2006 |
Carcinogenesis
|
0.050 |
AlteredExpression
|
phenotype |
BEFREE |
Furthermore, we found that the survival rate amongst the different low levels of HOXA5 expressing breast tumors was not significant, indicative of an early tumorigenesis process in the absence of innate levels of HOXA5 in normal breast cells.
|
17167183 |
2006 |
Mammary Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
RT-PCR and immunohistochemistry were performed, to assay the levels of HOXA5 expression, on a panel of normal breast tissue and its corresponding primary breast tumors.
|
17167183 |
2006 |
Mammary Neoplasms
|
0.040 |
AlteredExpression
|
group |
LHGDN |
HOXA5 regulates hMLH1 expression in breast cancer cells.
|
16756717 |
2006 |
Adenocarcinoma
|
0.020 |
Biomarker
|
group |
BEFREE |
Immunohistochemical analysis revealed that HOXA5 and A10 proteins were localized in the cytoplasm of tumor cells in both adenocarcinoma and squamous cell carcinoma tissues.
|
16525661 |
2006 |
Diaphragmatic Hernia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
[The etiology of congenital diaphragmatic hernia and esophageal atresia: the Hox genes].
|
18351244 |
2007 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
We have previously shown that HOXA5 induces apoptosis in breast cancer cells.
|
17804711 |
2007 |